lack of patients
RASTA
Efficacy and Tolerance of Transcutaneous Ionizing Radiations to Prevent Restenosis Caused by Intimal Hyperplasia on Prosthetic Haemodialysis Vascular Access
Sponsor study identifier
Secondary identifiers
interventional
5
1 country
5
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2009
Actual (reported)Study Completion
January 2009
Actual (reported)Although ionizing radiations have been proposed for the prevention of intimal hyperplasia in coronary and peripheral arteries, information is lacking on how irradiation may prevent neointimal smooth-muscle cell proliferation and restenosis on prosthetic haemodialysis vascular access. We will assess the preventive effect of one dose of radiations (14 Gy) administered transcutaneously one day after dilatation of stenosis on prosthetic haemodialysis vascular access in a randomized controlled trial with a standardized clinical and ultrasonographic one-year follow-up.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 20, 2006
Actual (reported)September 21, 2006
Actual (reported)December 2006
Date type not reportedThis date has not been verified as actual or estimated.
January 2009
Actual (reported)January 2009
Actual (reported)Thrombosis or stenosis > to 70% or indication of a new treatment of stenosis during the 12 month follow-up
1, 3, 6 and 12 month after initial angioplasty
Stenosis (> to 70%) or thrombosis or indication of a new treatment occurring
1, 3, 6 or 12 months after initial angioplasty
safety
1, 3, 6 and months after initial angioplasty
14 Gy ionizing radiations
14 Gy in one time
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Clinc Delay
Bayonne, 64100, France
Côte Basque Hospital
Bayonne, 64109, France
Clinic Saint Augustin
Bordeaux, 33000, France
Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux
Bordeaux, 33076, France
Clinic Francheville
Périgueux, 24000, France
Jean-Philippe MAIRE, Pr
University Hospital, Bordeaux, France
Paul Perez, Dr
University Hospital, Bordeaux, France
5 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2006
First Posted
September 21, 2006
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
January 2009
Actual (reported)Study Completion
January 2009
Actual (reported)Last Updated
March 18, 2015
Record last verified: 2015-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: